Table 3.
(A) Univariate Cox model | |||||
---|---|---|---|---|---|
Variable | All stages (n = 280) |
Stages I and II (n = 213) |
|||
Hazard ratio | P | Hazard ratio | P | ||
Age | 1.044 | <0.0001 | 1.057 | <0.0001 | |
Histology | Squamous cell vs. adenocarcinoma | 1.585 | 0.02 | 1.667 | 0.03 |
Tumor* | T 2 + 3 + 4 vs. T1 | 2.024 | 0.002 | — | — |
T2 + 3 vs. T1 | — | — | 2.175 | 0.002 | |
Lymph node* | N1 + 2 vs. N0 | 2.122 | 0.0003 | 2.531 | 0.0002 |
N1 vs. N0 | — | — | — | — | |
Tumor stage* | II + III + IV vs. I | 2.01 | 0.0005 | — | — |
II vs. I | — | — | 2.47 | 0.0002 | |
Fus1 score mean | 0.999 | 0.70 | 0.999 | 0.61 | |
Fus1 score level | Low † vs. negative ‡ | 0.535 | 0.06 | 0.502 | 0.07 |
Intermediate † vs. negative ‡ | 0.744 | 0.35 | 0.831 | 0.60 | |
High§ vs. negative‡ | 0.685 | 0.28 | 0.536 | 0.13 | |
(B) Multivariate Cox model | |||||
Variable |
All stages |
Stages I and II |
|||
Hazard ratio | P | Hazard ratio | P | ||
Age | 1.047 | <0.0001 | 1.059 | <0.0001 | |
Histology | Squamous cell vs. adenocarcinoma | 1.528 | 0.04 | 1.438 | 0.13 |
Tumor stage* | II + III + IV vs. I | 2.163 | 0.0002 | — | — |
II vs. I | — | — | 2.519 | 0.0004 | |
Fus1 score level | Low† vs. negative‡ | 0.357 | 0.002 | 0.312 | 0.003 |
Intermediate† vs. negative‡ | 0.474 | 0.02 | 0.544 | 0.10 | |
High§ vs. negative‡ | 0.518 | 0.06 | 0.415 | 0.03 |
Pathologic tumor, lymph node, and metastasis stage.
Low and intermediate, reduced Fus1 immunohistochemical expression.
Negative, absence of Fus1 immunohistochemical expression.
High, preserved or normal Fus1 immunohistochemical expression.